Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 133 of the 134 references it cites were found in a registry or an index.

Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease

Open access

Abstract

The spectrum of non-alcoholic fatty liver disease (NAFLD) ranges from simple hepatic steatosis, commonly associated with obesity, to non-alcoholic steatohepatitis, which can progress to fibrosis, cirrhosis and hepatocellular carcinoma. NAFLD pathophysiology involves environmental, genetic and metabolic factors, as well as changes in the intestinal microbiota and their products. Dysfunction of the intestinal barrier can contribute to NAFLD development and progression. Although there are technical limitations in assessing intestinal permeability in humans and the number of patients in these studies is rather small, fewer than half of the patients have increased intestinal permeability and translocation of bacterial products. Microbe-derived metabolites and the signalling pathways they affect might play more important roles in development of NAFLD. We review the microbial metabolites that contribute to the development of NAFLD, such as trimethylamine, bile acids, short-chain fatty acids and ethanol. We discuss the mechanisms by which metabolites produced by microbes might affect disease progression and/or serve as therapeutic targets or biomarkers for NAFLD.

Overview

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2018-316307

Cites

133 of 133 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 134 references

Cited by

See all 354

Metadata

Authors
Chu, H., Duan, Y., Yang, L., & Schnabl, B.
Affiliations
  • University of California San Diego (US)
  • Wuhan Union Hospital (CN)
Corresponding author
Schnabl, Bernd
Venue
Gut
Publisher
BMJ
Published
2018-08-31
Volume
68
Issue
2
Pages
359-370
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2888829195
Cited by
354
References
134
Citations by year
2026: 20 · 2025: 35 · 2024: 39 · 2023: 61 · 2022: 48 · 2021: 60 · 2020: 55 · 2019: 32 · 2018: 3
FWCI
3.67
Type
journal article
Language
en
Open access
Locations
  • Gut (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • National Institute on Alcohol Abuse and Alcoholism
  • National Natural Science Foundation of China
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords
non-alcoholic fatty liver disease, gut microbiota, microbial metabolites, trimethylamine, bile acids, short-chain fatty acids, ethanol, intestinal permeability, bacterial translocation, gut-liver axis, therapeutic target, hepatic steatosis, nonalcoholic steatohepatitis
MeSH terms
Gastrointestinal Microbiome, Ethanol, Bile Acids and Salts, Fatty Acids, Volatile, Humans, Methylamines, Risk Factors, Signal Transduction, Disease Progression, Dysbiosis, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. https://app.cochat.ai/papers/10.1136/gutjnl-2018-316307
The paper
Chu, H., Duan, Y., Yang, L., & Schnabl, B. (2019). Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. Gut. https://doi.org/10.1136/gutjnl-2018-316307

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.